MBRX - .80 Moleculin Announces Preparation to File an IND with the FDA for WP1220 for Treatment of Cutaneous T-Cell Lymphoma http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t92663696147&r=1497354683723 http://stockcharts.com/c-sc/sc?s=MBRX&p=W&b=5&g=0&i=t08467472790&r=1497356487338